Thumbnail

Stigma of Addiction Summit

June 8, 2022

AGENDA

11:30 - 12:20 Welcome Address and Recap from the 2021 Summit

Gary Mendell, Shatterproof
Cristina Rabadan-Diehl, ShatterProof Ambassador
Dr. Rahul Gupta, Office of National Drug Control Policy
Rachael Cooper, Shatterproof
Alanna Boulton, Dell Medical School at The University of Texas at Austin
12:20 - 12:50 Opening Plenary: More Than Just a voice at the table - Addiction Stigma and Advocates with Lived Experience

Sam Roberts, Columbia University
Dinah Ortiz, Bronx Defenders
Claire Clark, University of Kentucky

Learning Objectives:
  • Describe the concept of stigma and its role in addiction treatment and policy development
  • Understand the criticality of including the voices of people with lived experience in developing interventions and policy reforms
  • Including individuals with lived experience in the delivery of healthcare education
  • Demonstrate meaningful ways that individuals with lived experience have been included in setting the narrative around addiction treatment and policy development
12:50 - 1:00 Break
1:00 - 2:00

BREAKOUT SESSIONS

SESSION 1.1 - Harm Reduction and Intersectional Stigma


Kassandra Frederique, Drug Policy Alliance
Tamika Jackson, National Harm Reduction Coalition
Claire Zagorski, University of Texas at Austin College of Pharmacy

Learning Objectives: 

  • Define the principles of harm reduction
  • Demonstrate how harm reduction fits into the medical and chronic disease healthcare models
  • Describe how harm reduction is stigmatized by the general public as well as healthcare and policy professionals
  • Illustrate that the concept of harm reduction places individuals at the center of stigma reduction

SESSION 1.2 - Stigma in the Healthcare System

Deborah Finnell, Johns Hopkins School of Nursing
Richard Bottner, Colorado Hospital Association
Cheyenne Johnson, British Columbia Centre on Substance Use

Learning Objectives:

  • Explain how stigma of addiction and people who use drugs manifests in the primary and acute care settings

  • Describe how medical education perpetuates the stigma of addiction and people who use drugs
  • Summarize how healthcare professionals who treat/encounter people who use drugs experience stigma from other healthcare professionals and the healthcare system
  • Outline how various healthcare professionals interact with individuals who use drugs and can perpetuate or eliminate stigmatizing behaviors and how multilevel coordination is necessary

SESSION 1.3 - Addressing Stigma Through Advocacy

Joshua Sharfstein, Johns Hopkins Bloomberg School of Public Health
Tracie Gardner, Legal Action Center
Nicky Lewis, University of Kentucky

Learning Objectives:

  • Describe how drug policy is inherently racist and what actions are needed to address this
  • Compare the way that 12-step and abstinence-only programs have influenced policy development and carceral involvement
  • Understand what types of media and awareness campaigns work to bring awareness to and reduce addiction stigma
  • Analyze the way that addiction is depicted in the media and the way that those depictions can serve to reinforce stigmatizing beliefs 
2:00 - 2:10 Break
2:10 - 3:10 BREAKOUT SESSIONS

SESSION 2.1 - Interventions for Treatment and Recovery Stigma

Sean Fogler, Elevyst
Corrie Vilsaint, Harvard Medical School
Julia Lechuga, The University of Texas at El Paso

Learning Objectives:
  • Illustrate how the spectrum of addiction treatment and recovery is stigmatized by healthcare and policy professionals and the general public
  • Summarize how healthcare professionals who treat/encounter people who use drugs experience stigma
  • Outline how various patient populations can be better engaged in research around appropriate treatment methods and models
  • Identify best practices for research engagement in this vulnerable population to improve treatment and recovery pathways
SESSION 2.2 - Exploring the roots of Anti-Stigma in Anti-Racism Work

Tamika Spellman, Honoring Individual Power and Strength (HIPS)

Learning Objectives:
  • Provide examples of how systemic racism and stigma manifest and are related to each other
  • Understand how the concept of stigma has been framed within the context of the inherently racist war on drugs
  • Discuss the importance of meaningfully including individuals who experience the stigma of addiction and using drugs in work focused on anti-stigma and anti-racism

SESSION 2.3 - Addiction, Stigma, and the Carceral System

Morgan Godvin, Northeastern University
Brandon Del Pozo, Warren Alpert Medical School of Brown University
Shannon Gwin-Mitchell, Friends Research Institute

Learning Objectives:
  • Summarize how the carceral system increases and exacerbates inequities within marginalized populations
  • Understand how the carceral system serves to perpetuate the stigma and cycles of addiction 
  • Discuss how reentry and reintegration are and are not effectively executed for formerly incarcerated individuals
  • Appraise the availability, or lack thereof, of addiction treatment and recovery support services during incarceration and its correlation to risk of fatal overdose after release 
3:10 - 3:20 Break
3:20 - 3:50 INNOVATION SESSION

Learning Objectives:
  • Describe and demonstrate stigma research or reduction efforts that are being or have been deployed in the practice setting or in the general public
  • Present and discuss the efficacy and results of implemented stigma research and reduction efforts
  • Discuss the implications of implemented stigma research and reduction eff orts including wider applicability to the practice setting, knowledge development, and remaining gaps in research and practical application
3:50 - 4:00 Break
4:00 - 4:25 Closing Plenary: Where Do We Go Now – Looking Forward by Focusing on Young People and Preventions

Scott Hadland, Harvard Medical School

Learning Objectives:
  • Describe the importance of mindful and intentional language and issue framing when addressing drugs and drug use with youth
  • Understand the importance of engaging young people in the narrative around drugs in order to change sentiment and drive real change
  • Highlight the correlation of histories of trauma and generational substance use
  • Discuss the importance of tying in comprehensive resource provision with consideration of specific vulnerabilities and adverse childhood events
4:25 - 4:30 Closing Address

Rachael Cooper, Shatterproof
Alanna Boulton, Dell Medical School at The University of Texas at Austin


Continuing Education Credit


The American Society of Addiction Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is approved for 5 Social Work CEUs, LPC Credit CEUs, LMFT Credit CEUs, and General Contact Hours

Continuing Education Disclosure Information

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Society of Addiction Medicine (ASAM) and the National Academy of Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work provides continuing education in accordance with the criteria and standards of the Texas Board of Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists and Licensed Psychologist under Texas Administrative Code, Title 22, Part 34. § 781.509.

A link to document participation and claim CE will be provided at the conclusion of The Stigma of Addiction Summit.

Speakers

Rahul Gupta, MD, MPH, MBA, FACP

Rahul Gupta, MD, MPH, MBA, FACP

Director of National Drug Control Policy

Brandon del Pozo, PhD, MPA, MA

Brandon del Pozo, PhD, MPA, MA

Warren Alpert Medical School of Brown University

Deborah S. Finnell, PhD, RN, CARN-AP, FAAN

Deborah S. Finnell, PhD, RN, CARN-AP, FAAN

Professor Emerita at Johns Hopkins School of Nursing

Sean Fogler

Sean Fogler

Co-founder and consultant with Elevyst

Morgan Godvin

Morgan Godvin

Founder of Beats Overdose

Kassandra Frederique

Kassandra Frederique

Executive Director of the Drug Policy Alliance

Nicky Lewis, PhD

Nicky Lewis, PhD

Associate Professor at the University of Kentucky

Dinah Ortiz-Adames

Dinah Ortiz-Adames

Drug User, Humanitarian, Activist

Samuel Kelton Roberts, PhD

Samuel Kelton Roberts, PhD

Associate Professor at Columbia University

Joshua Sharfstein, PhD

Joshua Sharfstein, PhD

Professor at the Johns Hopkins Bloomberg School of Public Health

Tamika Spellman

Tamika Spellman

Policy and Community Engagement Manager for HIPS

Tamika Jackson

Tamika Jackson

Certified Experiential Specialist and member of the National Harm Reduction Coalitions

Corrie Vilsaint, PhD

Corrie Vilsaint, PhD

Principal investigator at the Recovery Research Institute and Center for Addiction Medicine

Rich Bottner

Rich Bottner

Director, Quality and Patient Safety, Colorado Hospital Association

Cheyenne Johnson

Cheyenne Johnson

Executive Director of BC Centre on Substance Use

Claire Clarke, PhD

Claire Clark, PhD, MPH

Associate Professor at the University of Kentucky

Scott Hadland

Scott Hadland

Chief of Adolescent and Young Adult Medicine at MassGeneral Hosptial

Julia Lechuga, PhD

Julia Lechuga, PhD

Associate Professor, University of Texas

Shannon Gwin Mitchell

Shannon Gwin Mitchell

Community Psychologist, Senior Research Scientist

Tracie Gardner

Tracie Gardner

Senior Vice President of Legal Action Center

Claire Zagorski

Claire Zagorski

Coordinator of PhARM Center, Director of Longhorn Stop the Bleed

Cristina Rabadán-Diehl, PhD, MPH

Cristina Rabadán-Diehl, PhD, MPH

PharmD and Shatterproof Ambassador

Steering Committee

Brea Perry

Brea Perry, Ph.D., M.A.

Indiana University

Katie Marks

Katie Marks, Ph.D., M.A

University of Kentucky

David Fiellin, MD

David Fiellin, MD

Yale School of Medicine

Aisha Salman, MPH

Aisha Salman, MPH

National Academy of Medicine

Courtney Townsel, MD, MSc

Courtney Townsel, MD, MSc

University of Michigan

Margot Savoy, MD, MPH, FAAFP

Margot Savoy, MD, MPH, FAAFP

Temple University

Mariah Francis, BA

Mariah Francis, BA

Harm Reduction Coalition

Gilberto Perez, MPH

Gilberto Perez, MPH

Texas Department of Health Services

Thumbnail

We have the opportunity to inform, collaborate, and eliminate stigma. The work done in this Summit will save the lives of valuable loved ones.

Gary Mendell, Shatterproof CEO

Complaints about this program may be made to:
TSBSWE
333 Guadalupe St., Tower 3, Room 900
Austin, TX 78701
512-305-7700
800-821-3205
bhec.texas.gov/texas-state-board-of-social-worker-examiners

Two adults hugging

Together, we can make a real, tangible change for those affected by addiction.

By donating today, you will give families the support they need. Where there’s help, there’s hope.

Give now